Immunovant Stock (IMVT)
Track Immunovant stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, TheStreet Pro portfolio activity, contributor watchlist signals, and Pro price levels.
IMVT
Immunovant
healthcare
$30.46
▲ +14.03 (+83.66%) past year
Market Cap
$6.39B
P/E Ratio
—
1Y Return
+83.66%
EPS (TTM)
-$2.77
Read the latest TheStreet Pro articles mentioning Immunovant, including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
0 articlesNo articles mentioning IMVT yet.
Daily Diary Mentions
0 mentionsNo diary mentions for IMVT yet.